Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET) Short-term Investments (2016 - 2026)

Metlife's Short-term Investments history spans 18 years, with the latest figure at $4.9 billion for Q1 2026.

  • Quarterly Short-term Investments fell 10.73% to $4.9 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $4.9 billion through Mar 2026, down 10.73% year-over-year, with the annual reading at $3.6 billion for FY2025, 30.16% down from the prior year.
  • Short-term Investments came in at $4.9 billion for Q1 2026, up from $3.6 billion in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $6.9 billion in Q2 2023 to a low of $3.0 billion in Q2 2022.
  • The 5-year median for Short-term Investments is $4.9 billion (2026), against an average of $4.9 billion.
  • Year-over-year, Short-term Investments crashed 75.01% in 2022 and then soared 127.44% in 2023.
  • Metlife's Short-term Investments stood at $4.9 billion in 2022, then grew by 22.49% to $6.0 billion in 2023, then decreased by 14.71% to $5.2 billion in 2024, then crashed by 30.16% to $3.6 billion in 2025, then skyrocketed by 37.41% to $4.9 billion in 2026.
  • Per Business Quant, the three most recent readings for MET's Short-term Investments are $4.9 billion (Q1 2026), $3.6 billion (Q4 2025), and $6.0 billion (Q3 2025).